Report Detail
Global Genomic Biomarkers Market Size, Status and Forecast 2021-2027
- RnM2708472 |
- 19 January, 2021 |
- Global |
- 91 Pages |
- QYResearch |
- Other
Genomic Biomarkers market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Genomic Biomarkers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Oncology
Cardiovascular Diseases
Neurological Diseases
Others
Segment by Application
Diagnostic and Research Laboratories
Hospitals
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Thermo Fisher Scientific
Roche
Aepodia
Myriad Genetics
Eurofins Scientific
QIAGEN
Bio-Rad Laboratories
Genomic Health
Liquid Genomics
Myriad Genetics
1 Report Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global Genomic Biomarkers Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
- 1.2.2 Oncology
- 1.2.3 Cardiovascular Diseases
- 1.2.4 Neurological Diseases
- 1.2.5 Others
- 1.3 Market by Application
- 1.3.1 Global Genomic Biomarkers Market Share by Application: 2016 VS 2021 VS 2027
- 1.3.2 Diagnostic and Research Laboratories
- 1.3.3 Hospitals
- 1.3.4 Others
- 1.4 Study Objectives
- 1.5 Years Considered
2 Global Growth Trends
- 2.1 Global Genomic Biomarkers Market Perspective (2016-2027)
- 2.2 Genomic Biomarkers Growth Trends by Regions
- 2.2.1 Genomic Biomarkers Market Size by Regions: 2016 VS 2021 VS 2027
- 2.2.2 Genomic Biomarkers Historic Market Share by Regions (2016-2021)
- 2.2.3 Genomic Biomarkers Forecasted Market Size by Regions (2022-2027)
- 2.3 Genomic Biomarkers Industry Dynamic
- 2.3.1 Genomic Biomarkers Market Trends
- 2.3.2 Genomic Biomarkers Market Drivers
- 2.3.3 Genomic Biomarkers Market Challenges
- 2.3.4 Genomic Biomarkers Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Top Genomic Biomarkers Players by Revenue
- 3.1.1 Global Top Genomic Biomarkers Players by Revenue (2016-2021)
- 3.1.2 Global Genomic Biomarkers Revenue Market Share by Players (2016-2021)
- 3.2 Global Genomic Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Players Covered: Ranking by Genomic Biomarkers Revenue
- 3.4 Global Genomic Biomarkers Market Concentration Ratio
- 3.4.1 Global Genomic Biomarkers Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by Genomic Biomarkers Revenue in 2020
- 3.5 Genomic Biomarkers Key Players Head office and Area Served
- 3.6 Key Players Genomic Biomarkers Product Solution and Service
- 3.7 Date of Enter into Genomic Biomarkers Market
- 3.8 Mergers & Acquisitions, Expansion Plans
4 Genomic Biomarkers Breakdown Data by Type
- 4.1 Global Genomic Biomarkers Historic Market Size by Type (2016-2021)
- 4.2 Global Genomic Biomarkers Forecasted Market Size by Type (2022-2027)
5 Genomic Biomarkers Breakdown Data by Application
- 5.1 Global Genomic Biomarkers Historic Market Size by Application (2016-2021)
- 5.2 Global Genomic Biomarkers Forecasted Market Size by Application (2022-2027)
6 North America
- 6.1 North America Genomic Biomarkers Market Size (2016-2027)
- 6.2 North America Genomic Biomarkers Market Size by Type
- 6.2.1 North America Genomic Biomarkers Market Size by Type (2016-2021)
- 6.2.2 North America Genomic Biomarkers Market Size by Type (2022-2027)
- 6.2.3 North America Genomic Biomarkers Market Size by Type (2016-2027)
- 6.3 North America Genomic Biomarkers Market Size by Application
- 6.3.1 North America Genomic Biomarkers Market Size by Application (2016-2021)
- 6.3.2 North America Genomic Biomarkers Market Size by Application (2022-2027)
- 6.3.3 North America Genomic Biomarkers Market Size by Application (2016-2027)
- 6.4 North America Genomic Biomarkers Market Size by Country
- 6.4.1 North America Genomic Biomarkers Market Size by Country (2016-2021)
- 6.4.2 North America Genomic Biomarkers Market Size by Country (2022-2027)
- 6.4.3 United States
- 6.4.3 Canada
7 Europe
- 7.1 Europe Genomic Biomarkers Market Size (2016-2027)
- 7.2 Europe Genomic Biomarkers Market Size by Type
- 7.2.1 Europe Genomic Biomarkers Market Size by Type (2016-2021)
- 7.2.2 Europe Genomic Biomarkers Market Size by Type (2022-2027)
- 7.2.3 Europe Genomic Biomarkers Market Size by Type (2016-2027)
- 7.3 Europe Genomic Biomarkers Market Size by Application
- 7.3.1 Europe Genomic Biomarkers Market Size by Application (2016-2021)
- 7.3.2 Europe Genomic Biomarkers Market Size by Application (2022-2027)
- 7.3.3 Europe Genomic Biomarkers Market Size by Application (2016-2027)
- 7.4 Europe Genomic Biomarkers Market Size by Country
- 7.4.1 Europe Genomic Biomarkers Market Size by Country (2016-2021)
- 7.4.2 Europe Genomic Biomarkers Market Size by Country (2022-2027)
- 7.4.3 Germany
- 7.4.4 France
- 7.4.5 U.K.
- 7.4.6 Italy
- 7.4.7 Russia
- 7.4.8 Nordic
8 Asia-Pacific
- 8.1 Asia-Pacific Genomic Biomarkers Market Size (2016-2027)
- 8.2 Asia-Pacific Genomic Biomarkers Market Size by Type
- 8.2.1 Asia-Pacific Genomic Biomarkers Market Size by Type (2016-2021)
- 8.2.2 Asia-Pacific Genomic Biomarkers Market Size by Type (2022-2027)
- 8.2.3 Asia-Pacific Genomic Biomarkers Market Size by Type (2016-2027)
- 8.3 Asia-Pacific Genomic Biomarkers Market Size by Application
- 8.3.1 Asia-Pacific Genomic Biomarkers Market Size by Application (2016-2021)
- 8.3.2 Asia-Pacific Genomic Biomarkers Market Size by Application (2022-2027)
- 8.3.3 Asia-Pacific Genomic Biomarkers Market Size by Application (2016-2027)
- 8.4 Asia-Pacific Genomic Biomarkers Market Size by Region
- 8.4.1 Asia-Pacific Genomic Biomarkers Market Size by Region (2016-2021)
- 8.4.2 Asia-Pacific Genomic Biomarkers Market Size by Region (2022-2027)
- 8.4.3 China
- 8.4.4 Japan
- 8.4.5 South Korea
- 8.4.6 Southeast Asia
- 8.4.7 India
- 8.4.8 Australia
9 Latin America
- 9.1 Latin America Genomic Biomarkers Market Size (2016-2027)
- 9.2 Latin America Genomic Biomarkers Market Size by Type
- 9.2.1 Latin America Genomic Biomarkers Market Size by Type (2016-2021)
- 9.2.2 Latin America Genomic Biomarkers Market Size by Type (2022-2027)
- 9.2.3 Latin America Genomic Biomarkers Market Size by Type (2016-2027)
- 9.3 Latin America Genomic Biomarkers Market Size by Application
- 9.3.1 Latin America Genomic Biomarkers Market Size by Application (2016-2021)
- 9.3.2 Latin America Genomic Biomarkers Market Size by Application (2022-2027)
- 9.3.3 Latin America Genomic Biomarkers Market Size by Application (2016-2027)
- 9.4 Latin America Genomic Biomarkers Market Size by Country
- 9.4.1 Latin America Genomic Biomarkers Market Size by Country (2016-2021)
- 9.4.2 Latin America Genomic Biomarkers Market Size by Country (2022-2027)
- 9.4.3 Mexico
- 9.4.4 Brazil
10 Middle East & Africa
- 10.1 Middle East & Africa Genomic Biomarkers Market Size (2016-2027)
- 10.2 Middle East & Africa Genomic Biomarkers Market Size by Type
- 10.2.1 Middle East & Africa Genomic Biomarkers Market Size by Type (2016-2021)
- 10.2.2 Middle East & Africa Genomic Biomarkers Market Size by Type (2022-2027)
- 10.2.3 Middle East & Africa Genomic Biomarkers Market Size by Type (2016-2027)
- 10.3 Middle East & Africa Genomic Biomarkers Market Size by Application
- 10.3.1 Middle East & Africa Genomic Biomarkers Market Size by Application (2016-2021)
- 10.3.2 Middle East & Africa Genomic Biomarkers Market Size by Application (2022-2027)
- 10.3.3 Middle East & Africa Genomic Biomarkers Market Size by Application (2016-2027)
- 10.4 Middle East & Africa Genomic Biomarkers Market Size by Country
- 10.4.1 Middle East & Africa Genomic Biomarkers Market Size by Country (2016-2021)
- 10.4.2 Middle East & Africa Genomic Biomarkers Market Size by Country (2022-2027)
- 10.4.3 Turkey
- 10.4.4 Saudi Arabia
- 10.4.5 UAE
11 Key Players Profiles
- 11.1 Thermo Fisher Scientific
- 11.1.1 Thermo Fisher Scientific Company Details
- 11.1.2 Thermo Fisher Scientific Business Overview
- 11.1.3 Thermo Fisher Scientific Genomic Biomarkers Introduction
- 11.1.4 Thermo Fisher Scientific Revenue in Genomic Biomarkers Business (2016-2021)
- 11.1.5 Thermo Fisher Scientific Recent Development
- 11.2 Roche
- 11.2.1 Roche Company Details
- 11.2.2 Roche Business Overview
- 11.2.3 Roche Genomic Biomarkers Introduction
- 11.2.4 Roche Revenue in Genomic Biomarkers Business (2016-2021)
- 11.2.5 Roche Recent Development
- 11.3 Aepodia
- 11.3.1 Aepodia Company Details
- 11.3.2 Aepodia Business Overview
- 11.3.3 Aepodia Genomic Biomarkers Introduction
- 11.3.4 Aepodia Revenue in Genomic Biomarkers Business (2016-2021)
- 11.3.5 Aepodia Recent Development
- 11.4 Myriad Genetics
- 11.4.1 Myriad Genetics Company Details
- 11.4.2 Myriad Genetics Business Overview
- 11.4.3 Myriad Genetics Genomic Biomarkers Introduction
- 11.4.4 Myriad Genetics Revenue in Genomic Biomarkers Business (2016-2021)
- 11.4.5 Myriad Genetics Recent Development
- 11.5 Eurofins Scientific
- 11.5.1 Eurofins Scientific Company Details
- 11.5.2 Eurofins Scientific Business Overview
- 11.5.3 Eurofins Scientific Genomic Biomarkers Introduction
- 11.5.4 Eurofins Scientific Revenue in Genomic Biomarkers Business (2016-2021)
- 11.5.5 Eurofins Scientific Recent Development
- 11.6 QIAGEN
- 11.6.1 QIAGEN Company Details
- 11.6.2 QIAGEN Business Overview
- 11.6.3 QIAGEN Genomic Biomarkers Introduction
- 11.6.4 QIAGEN Revenue in Genomic Biomarkers Business (2016-2021)
- 11.6.5 QIAGEN Recent Development
- 11.7 Bio-Rad Laboratories
- 11.7.1 Bio-Rad Laboratories Company Details
- 11.7.2 Bio-Rad Laboratories Business Overview
- 11.7.3 Bio-Rad Laboratories Genomic Biomarkers Introduction
- 11.7.4 Bio-Rad Laboratories Revenue in Genomic Biomarkers Business (2016-2021)
- 11.7.5 Bio-Rad Laboratories Recent Development
- 11.8 Genomic Health
- 11.8.1 Genomic Health Company Details
- 11.8.2 Genomic Health Business Overview
- 11.8.3 Genomic Health Genomic Biomarkers Introduction
- 11.8.4 Genomic Health Revenue in Genomic Biomarkers Business (2016-2021)
- 11.8.5 Genomic Health Recent Development
- 11.9 Liquid Genomics
- 11.9.1 Liquid Genomics Company Details
- 11.9.2 Liquid Genomics Business Overview
- 11.9.3 Liquid Genomics Genomic Biomarkers Introduction
- 11.9.4 Liquid Genomics Revenue in Genomic Biomarkers Business (2016-2021)
- 11.9.5 Liquid Genomics Recent Development
- 11.10 Epigenomics
- 11.10.1 Epigenomics Company Details
- 11.10.2 Epigenomics Business Overview
- 11.10.3 Epigenomics Genomic Biomarkers Introduction
- 11.10.4 Epigenomics Revenue in Genomic Biomarkers Business (2016-2021)
- 11.10.5 Epigenomics Recent Development
- 11.11 AROS Applied Biotechnology
- 11.11.1 AROS Applied Biotechnology Company Details
- 11.11.2 AROS Applied Biotechnology Business Overview
- 11.11.3 AROS Applied Biotechnology Genomic Biomarkers Introduction
- 11.11.4 AROS Applied Biotechnology Revenue in Genomic Biomarkers Business (2016-2021)
- 11.11.5 AROS Applied Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Disclaimer
Summary:
Get latest Market Research Reports on Genomic Biomarkers . Industry analysis & Market Report on Genomic Biomarkers is a syndicated market report, published as Global Genomic Biomarkers Market Size, Status and Forecast 2021-2027. It is complete Research Study and Industry Analysis of Genomic Biomarkers market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
